Status:
RECRUITING
Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis
Lead Sponsor:
University of California, San Diego
Conditions:
Osteo Arthritis Knee
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the safety and effectiveness of bone marrow aspirate concentrate (BMAC) in patients with moderate to severe osteoarthritis of the knee. BMAC provides a rich...
Detailed Description
This is a pilot open-label, non-randomized, single institution study of BMAC administration in patient's with moderate to severe osteoarthritis of the knee who will undergo total knee replacement. Sev...
Eligibility Criteria
Inclusion
- Kellgren Lawrence radiographic grade IV
- Need for a total knee arthroscopy by the patients primary care provider/or orthopedist.
- Persistent pain in target knee that is unresponsive to standard of care including acetametaphine, non-steroidal anti-inflammatory drugs, physical therapy and/or intraarticular corticosteroids and/or hyaluronic acid preparations.
- Males or females aged 45-75.
Exclusion
- \-
Key Trial Info
Start Date :
July 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04716803
Start Date
July 8 2020
End Date
December 31 2023
Last Update
January 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Diego Koman Outpatient Pavilion
La Jolla, California, United States, 92037